Error: Could not add to watchlist. X

Cellestis Ltd

+ Watchlist
CST:AU
Acquired
CST:AU was acquired by QGEN:US
AUD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
0.10
Market Cap (AUD)
-
Shares Outstanding (m)
96.152
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Medical Equipment & Devices
Sub-Industry
Life Science Equipment
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cellestis Limited operates as a biotechnology company. The Company manufactures and markets QuantiFERON products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses using whole blood samples.
ADDRESS
Level 1 Office Tower 2
1341 Dandenong Road
Chadstone, VIC
Australia
PHONE
61-3-8527-3500
  • Ronald George Pitcher "Ron"
    Chairman
  • Anthony John Radford
    Managing Dir/CEO/Founder
  • James S Rothel
    Exec Dir/Chief Scientific Ofcr
  • Brian H Manuel
    CFO/Secretary
  • P J Prather
    Chief Marketing Officer
Show More